Posted by Michael Wonder on 06 May 2021
Viome receives FDA approval for its unique mRNA technology and AI platform to detect cancers
6 May 2021 - FDA breakthrough designation validates Viome's proprietary mRNA analysing technology and state of the art AI platform to screen for oral cancer and throat cancer.
Viome today announced its proprietary mRNA analysis technology combined with its next-generation AI platform has been designated a breakthrough device by The FDA for early detection of oral cancer and throat cancer.
